Vitamin D and subsequent all-age and premature mortality: A systematic review

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Rush, Lynne ^a   McCartney, Gerry ^b   Walsh, David ^c   Mackay, Daniel ^d  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b NHS HEALTH SCOTLAND   (United Kingdom)

^c Glasgow Centre for Population Health   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

25OHD; Meta analysis; Premature mortality; Systematic review; Vitamin D

Indexed keywords

ADULT; AGED; EPIDEMIOLOGY; FEMALE; HUMAN; INCIDENCE; MALE; META ANALYSIS; MIDDLE AGED; MORTALITY; PREMATURE MORTALITY; UNITED KINGDOM; VITAMIN D DEFICIENCY;

ADULT; AGED; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY, PREMATURE; VITAMIN D DEFICIENCY;

EID: 84880362613     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-679     Document Type: Review

References (42)

1. Vitamin D deficiency and risk of cardiovascular disease. Wang TJ, Pencina MJ, Booth SL, et al. Circulation 2008 117 4 503 511 10.1161/CIRCULATIONAHA.107. 706127 18180395
2. Vitamin D and cardiovascular disease: Systematic review and meta-analysis of prospective studies. Grandi NC, Breitling LP, Brenner H, Prev Med 2010 51 3-4 228 233 20600257
3. Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis. Elamin MB, Abu Elnour NO, Elamin KB, et al. J Clin End & Metab 2011 96 7 1931 1942 10.1210/jc.2011-0398
4. Vitamin D and type 2 diabetes: A systematic review. Mitri J, Muraru MD, Pittas AG, Eur J Clin Nutr 2011 65 9 1005 1015 10.1038/ejcn.2011.118 21731035
5. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Gandini S, Boniol M, Haukka J, et al. Int J Cancer 2011 128 6 1414 1424 10.1002/ijc.25439 20473927
6. Overview of the cohort consortium vitamin D pooling project of rarer cancers. Helzlsouer KJ, VDPP Steering C, Am J Epidemiol 2010 172 1 4 9 10.1093/aje/kwq119 20562193
7. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, et al. Am J Epidemiol 2010 172 1 81 93 10.1093/aje/kwq120 20562185
8. Vitamin D, and public health: An overview of recent research on common diseases and mortality in adulthood. Scragg R, Public Health Nutr 2011 14 9 1515 1532 10.1017/S1368980011001455 21729467
9. Vitamin D supplementation and total mortality-a meta-analysis of randomized controlled trials. Autier P, Gandini S, Arch Intern Med 2007 167 16 1730 1737 10.1001/archinte.167.16.1730 17846391 (Pubitemid 47403059)
10. Vitamin D supplementation for prevention of mortality in adults. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Gluud C, Cochrane Database Syst Rev 2011 7 CD007470 10.1002/14651858.CD007470.pub2
11. Vitamin D deficiency and mortality risk in the general population: A meta-analysis of prospective cohort studies. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S, Am J Clin Nutr 2012 95 1 91 100 10.3945/ajcn.111.014779 22170374
12. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Schöttker B, Ball D, Gellert C, Brenner H, Ageing Res Rev 2013 12 2 708 718 10.1016/j.arr.2012.02. 004 22343489
13. Gillie O, An explanation and a plan. Health Research Forum. Report 2008 http://www.healthresearchforum.org.uk/reports.html (accessed 2nd August, 2012)
14. McCartney G, Collins C, Walsh D, Batty D, Accounting for Scotland's excess mortality: Towards a synthesis. Glasgow Centre for Population Health. Report 2011 http://www.gcph.co.uk/publications/238-accounting-for-scotlands- excess-mortality-towards-a-synthesis (accessed 2nd August, 2012) 23826505
15. Deprivation and mortality in Scotland, 1981 and 1991. McLoone P, Boddy FA, BMJ 1994 309 6967 1465 1470 10.1136/bmj.309.6967.1465 7804046 (Pubitemid 24360984)
16. Cause-specific inequalities in mortality in Scotland: Two decades of change. A population-based study. Leyland AH, Dundas R, McLoone P, Boddy FA, BMC Public Health. 2007 7 172 10.1186/1471-2458-7-172 17650304 (Pubitemid 47222129)
17. Rising premature mortality in the UK's persistently deprived areas: only a Scottish phenomenon? Norman P, Boyle P, Exeter D, Feng Z, Popham F, Soc Sci Med 2011 73 11 1575 1584 10.1016/j.socscimed.2011.09.034 22030211
18. Why is mortality higher in Scotland than in England and Wales? Decreasing influence of socioeconomic deprivation between 1981 and 2001 supports the existence of a 'Scottish effect'. Hanlon P, Lawder RS, Buchanan D, et al. J Public Health 2005 27 2 199 204 10.1093/pubmed/fdi002 (Pubitemid 40933851)
19. Hypovitaminosis D in British adults at age 45 y: Nationwide cohort study of dietary and lifestyle predictors. Hyppönen E, Power C, Am J Clin Nutr 2007 85 3 860 868 17344510 (Pubitemid 46393520)
20. It's not 'just deprivation': Why do equally deprived UK cities experience different health outcomes? Walsh D, Bendel N, Jones R, Hanlon P, Public Health 2010 124 9 487 495 10.1016/j.puhe.2010.02.006 20223487
21. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma G, BMJ 2009 339 2535 10.1136/bmj.b2535 19622551
22. CASP tool for cohort studies http://www.casp-uk.net/wp-content/uploads/ 2011/11/CASP-Cohort-Study-Checklist-31.05.13.pdf (accessed 29th July 2013)
23. Metan: Fixed- and random-effects meta-analysis. Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Sterne JAC, Stata J 2008 8 1 3 28
24. Effect sizes based on binary data (2 x 2 tables). Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, Introduction to meta-analysis Wiley 2009 33 38
25. Serum concentrations of 17beta-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men-the MINOS study. Szulc P, Claustrat B, Delmas PD, Clin Endocrinol (Oxf) 2009 71 4 594 602 10.1111/j.1365-2265.2009.03530.x
26. Funnel plots in meta-analysis. Sterne JAC, Harbord RM, J Stata 2004 4 2 127 141
27. Meta-regression in stata. Harbord RM, Higgins JPT, J Stata 2008 8 4 493 519
28. A study of relationships between bone-related vitamins and minerals, related risk markers, and subsequent mortality in older British people: The national diet and nutrition survey of people aged 65 years and over. Bates CJ, Hamer M, Mishra GD, Osteoporosis Int 2012 23 2 457 466 10.1007/s00198-011-1543-z
29. Vitamin D and all-cause mortality among adults in USA: Findings from the national health and nutrition examination survey linked mortality study. Ford ES, Zhao G, Tsai J, Li C, Int J Epidemiol 2011 40 4 998 1005 10.1093/ije/dyq264 21266455
30. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. Ginde AA, Scragg R, Schwartz RS, Jr Camargo CA, J Am Geriatr Soc 2009 57 9 1595 1603 10.1111/j.1532-5415.2009.02359.x 19549021
31. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: The Tromso study. Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R, Eur J Endocrinol 2010 162 5 935 942 10.1530/EJE-09-1041 20185562
32. Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Jia X, Aucott LS, McNeill G, Br J Nutr 2007 98 3 593 599 10.1017/S0007114507725163 17442130 (Pubitemid 47272875)
33. Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden. Johansson H, Oden A, Kanis J, et al. Osteoporosis Int 2012 23 3 991 999 10.1007/s00198-011-1809-5
34. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Melamed ML, Michos ED, Post W, Astor B, Arch Intern Med 2008 168 15 1629 1637 10.1001/archinte.168.15.1629 18695076
35. Plasma vitamin D and mortality in older men: A community-based prospective cohort study. Michaelsson K, Baron JA, Snellman G, et al. Am J Clin Nutr 2010 92 4 841 848 10.3945/ajcn.2010.29749 20720256
36. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Semba RD, Houston DK, Bandinelli S, et al. Eur J Clin Nutr 2010 64 2 203 209 10.1038/ejcn.2009.140 19953106
37. Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Virtanen JK, Nurmi T, Voutilainen S, Mursu J, Tuomainen TP, Eur J Nutr 2011 50 5 305 312 10.1007/s00394-010-0138-3 20976461
38. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Visser M, Deeg DJH, Puts MTE, Seidell JC, Lips P, Am J Clin Nutr 2006 84 3 616 622 16960177 (Pubitemid 44713413)
39. Bates C, Mishra G, Updated hazard ratios for 25OHD and all-cause mortality, data from the national diet and nutrition survey of people aged 65 years and over Personal communication 2012
40. Obesity and renal cell cancer-a quantitative review. Bergstrom A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A, Br J Cancer 2001 85 984 990 10.1054/bjoc.2001.2040 11592770 (Pubitemid 33016001)
41. An empirical study using permutation-based resampling in meta-regression. Gagnier J, Moher D, Boon H, Bombardier C, Beyene J, Syst Rev 2012 1 1 18 10.1186/2046-4053-1-18 22587815
42. The assessment of circulating 25(OH)D and 1,25(OH)2D: Where we are and where we are going. Hollis BW, Horst RL, J Ster Biochem Mol Biol 2007 103 3-5 473 476 (Pubitemid 46401282)